Although RNF183 is found upregulated in inflammatory bowel disease (IBD), a disease highly associated with CRC, and activates classic NF-κB pathway,12, 13, 14 its role in cancer cells remains largely unknown. Here, RNF183 is linked to colorectal carcinoma.